Gain Therapeutics Inc. (GANX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gain Therapeutics Inc.

    NASDAQ: GANX · Real-Time Price · USD
    1.76
    0.02 (1.15%)
    At close: Sep 05, 2025, 3:59 PM
    1.78
    1.14%
    After-hours: Sep 05, 2025, 07:54 PM EDT

    Gain Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 55.18K 140.11K 164.99K
    Cost of Revenue
    		 84.07K 80.38K 64.17K 7.16M
    Gross Profit
    		 -84.07K -25.2K 75.94K -7M
    Operating Income
    		 -20.35M -22.25M -17.78M -13.83M
    Interest Income
    		 357.1K 494.23K 375.36K 12.49K
    Pretax Income
    		 -19.87M -22.19M -17.5M -13.89M
    Net Income
    		 -20.41M -22.27M -17.59M -13.89M
    Selling & General & Admin
    		 9.56M 10.79M 9.54M 6.83M
    Research & Development
    		 10.79M 11.52M 8.38M 7.16M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 20.35M 22.31M 17.92M 13.99M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -20.35M 22.31M 17.92M 13.99M
    Income Tax Expense
    		 536.82K 79.28K 92.98K 4.01K
    Shares Outstanding (Basic)
    		 22.88M 13.01M 11.88M 10.17M
    Shares Outstanding (Diluted)
    		 22.88M 13.01M 11.88M 10.17M
    EPS (Basic)
    		 -0.89 -1.71 -1.48 -1.37
    EPS (Diluted)
    		 -0.89 -1.71 -1.48 -1.37
    EBITDA
    		 -19.79M -22.17M -17.78M -13.82M
    EBIT
    		 -19.87M -22.25M -17.78M -13.83M
    Depreciation & Amortization
    		 84.07K 83.58K 64.17K 15.48K

    Add to Watchlist